Categories
Blood Cancer

CAR-T therapy in multiple myeloma: research blind spots [Video]

CAR-T therapy in multiple myeloma: research blind spots

CAR T-cell therapy has been shown to elicit high-quality responses in patients with multiple myeloma. Positive data from the pivotal Phase II KarMMa trial led to the approval of idecabtagene vicleucel, a BCMA-directed CAR T-cell therapy, in patients with heavily pretreated relapsed/refractory myeloma, and ongoing trials are investigating the utility of CAR-T versus standard of care regimens in earlier lines of treatment. Andrew Cowan, MD, University of Washington, Seattle, WA, discusses the blind spots in myeloma CAR-T research, highlighting key topics such as treatment sequencing, combination studies, and retreatment with BCMA-targeted therapies. This interview took place at during 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

Watch/Read More
Categories
Blood Cancer

The role of selinexor in the treatment of multiple myeloma [Video]

In this video, Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the role of selinexor in the treatment of multiple myeloma, emphasizing its value in patients with del(17p)-positive relapsed/refractory (R/R) disease. Dr Richardson also highlights some of the challenges associated with the use of selinexor, and clinical trials evaluating the safety and efficacy of this agent. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Categories
Blood Cancer

New ProPublica investigation reveals racist environmental "sacrifice zones" [Video]

In a new investigation, ProPublica reporters Lylla Younes, Ava Kofman, Al Shaw, Lisa Song, and Maya Miller used EPA data processing software to examine the spread of cancer-causing chemicals and other hazardous air pollutions in communities across the United States. At the maps intimate scale, its possible to see up close how a massive chemical

Categories
Blood Cancer

How Long will a Patient Remain in the Hospital after CAR-T Reinfusion? [Video]

HealthTree University, provided by the HealthTree Foundation, offers a comprehensive online multiple myeloma curriculum with lessons, quizzes and course discussion. Learn for free at https://www.healthtree.org. Topics covered include: myeloma basics, testing and blood markers, stem cell transplant, financial resources, immunotherapies, myeloma genetics and much more. We've partnered with over 100 myeloma experts to help you learn quickly. Improve the way you navigate your disease and obtain better outcomes with HealthTree University.Follow HealthTree:Twitter: https://www.twitter.com/healthtreeformmFacebook: https://www.facebook.com/healthtreeformultiplemyelomaInstagram: https://www.instragram.com/healthtreeformultiplemyeloma